Clever Leaves EV/EBIT
Quel est le EV/EBIT de Clever Leaves?
Le EV/EBIT de Clever Leaves Holdings Inc. est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à Clever Leaves
Que fait Clever Leaves?
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
Entreprises avec ev/ebit similaire à Clever Leaves
- TV Vision a EV/EBIT de N/A
- NextTrip a EV/EBIT de N/A
- Cor Infrastructure Trust Inc a EV/EBIT de N/A
- Entera Bio Ltd a EV/EBIT de N/A
- Sensyne Health plc a EV/EBIT de N/A
- Tocagen a EV/EBIT de N/A
- Clever Leaves a EV/EBIT de N/A
- Ucommune International Ltd a EV/EBIT de N/A
- Ashford Inc a EV/EBIT de N/A
- Akerna Corp a EV/EBIT de N/A
- ThreeD Capital a EV/EBIT de N/A
- Surgalign a EV/EBIT de N/A
- Regulus Therapeutics Inc a EV/EBIT de N/A